Cargando…

Herd immunity, vaccination and moral obligation

The public health benefits of herd immunity are often used as the justification for coercive vaccine policies. Yet, ‘herd immunity’ as a term has multiple referents, which can result in ambiguity, including regarding its role in ethical arguments. The term ‘herd immunity’ can refer to (1) the herd i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bullen, Matthew, Heriot, George S, Jamrozik, Euzebiusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511978/
https://www.ncbi.nlm.nih.gov/pubmed/37277175
http://dx.doi.org/10.1136/jme-2022-108485
_version_ 1785108264421163008
author Bullen, Matthew
Heriot, George S
Jamrozik, Euzebiusz
author_facet Bullen, Matthew
Heriot, George S
Jamrozik, Euzebiusz
author_sort Bullen, Matthew
collection PubMed
description The public health benefits of herd immunity are often used as the justification for coercive vaccine policies. Yet, ‘herd immunity’ as a term has multiple referents, which can result in ambiguity, including regarding its role in ethical arguments. The term ‘herd immunity’ can refer to (1) the herd immunity threshold, at which models predict the decline of an epidemic; (2) the percentage of a population with immunity, whether it exceeds a given threshold or not; and/or (3) the indirect benefit afforded by collective immunity to those who are less immune. Moreover, the accumulation of immune individuals in a population can lead to two different outcomes: elimination (for measles, smallpox, etc) or endemic equilibrium (for COVID-19, influenza, etc). We argue that the strength of a moral obligation for individuals to contribute to herd immunity through vaccination, and by extension the acceptability of coercion, will depend on how ‘herd immunity’ is interpreted as well as facts about a given disease or vaccine. Among other things, not all uses of ‘herd immunity’ are equally valid for all pathogens. The optimal conditions for herd immunity threshold effects, as illustrated by measles, notably do not apply to the many pathogens for which reinfections are ubiquitous (due to waning immunity and/or antigenic variation). For such pathogens, including SARS-CoV-2, mass vaccination can only be expected to delay rather than prevent new infections, in which case the obligation to contribute to herd immunity is much weaker, and coercive policies less justifiable.
format Online
Article
Text
id pubmed-10511978
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-105119782023-09-22 Herd immunity, vaccination and moral obligation Bullen, Matthew Heriot, George S Jamrozik, Euzebiusz J Med Ethics Original Research The public health benefits of herd immunity are often used as the justification for coercive vaccine policies. Yet, ‘herd immunity’ as a term has multiple referents, which can result in ambiguity, including regarding its role in ethical arguments. The term ‘herd immunity’ can refer to (1) the herd immunity threshold, at which models predict the decline of an epidemic; (2) the percentage of a population with immunity, whether it exceeds a given threshold or not; and/or (3) the indirect benefit afforded by collective immunity to those who are less immune. Moreover, the accumulation of immune individuals in a population can lead to two different outcomes: elimination (for measles, smallpox, etc) or endemic equilibrium (for COVID-19, influenza, etc). We argue that the strength of a moral obligation for individuals to contribute to herd immunity through vaccination, and by extension the acceptability of coercion, will depend on how ‘herd immunity’ is interpreted as well as facts about a given disease or vaccine. Among other things, not all uses of ‘herd immunity’ are equally valid for all pathogens. The optimal conditions for herd immunity threshold effects, as illustrated by measles, notably do not apply to the many pathogens for which reinfections are ubiquitous (due to waning immunity and/or antigenic variation). For such pathogens, including SARS-CoV-2, mass vaccination can only be expected to delay rather than prevent new infections, in which case the obligation to contribute to herd immunity is much weaker, and coercive policies less justifiable. BMJ Publishing Group 2023-09 2023-06-05 /pmc/articles/PMC10511978/ /pubmed/37277175 http://dx.doi.org/10.1136/jme-2022-108485 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Research
Bullen, Matthew
Heriot, George S
Jamrozik, Euzebiusz
Herd immunity, vaccination and moral obligation
title Herd immunity, vaccination and moral obligation
title_full Herd immunity, vaccination and moral obligation
title_fullStr Herd immunity, vaccination and moral obligation
title_full_unstemmed Herd immunity, vaccination and moral obligation
title_short Herd immunity, vaccination and moral obligation
title_sort herd immunity, vaccination and moral obligation
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511978/
https://www.ncbi.nlm.nih.gov/pubmed/37277175
http://dx.doi.org/10.1136/jme-2022-108485
work_keys_str_mv AT bullenmatthew herdimmunityvaccinationandmoralobligation
AT heriotgeorges herdimmunityvaccinationandmoralobligation
AT jamrozikeuzebiusz herdimmunityvaccinationandmoralobligation